首页> 外国专利> EMPLOYMENT OF DERIVATIVES OF TIAZOLIDINODIONA AND CORRESPONDING ANTI-HERITAGE AGENTS FOR THE TREATMENT OF PATHOLOGICAL STATES WITH RISK OF EVOLUTIONING IN NON-INSULINODEPENDENT MELLITUS DIABETES.

EMPLOYMENT OF DERIVATIVES OF TIAZOLIDINODIONA AND CORRESPONDING ANTI-HERITAGE AGENTS FOR THE TREATMENT OF PATHOLOGICAL STATES WITH RISK OF EVOLUTIONING IN NON-INSULINODEPENDENT MELLITUS DIABETES.

机译:治疗非病态依赖型糖尿病的病理状态伴有发展风险的替唑替尼酮衍生物和相应的抗遗传剂的治疗。

摘要

NEW METHODS ARE PRESENTED FOR USING DERIVATIVES OF TIAZOLIDINONE AND RELATED ANTI-HERITAGE AGENTS TO TREAT THE POPULATION WITH THE RISK OF DEVELOPING MELITUS OF THE DIABETES NOT DEPENDING ON INSULIN (NIDDM) AND THE COMPLICATIONS THAT MAKE. IN A CONFORMATION, THE COMPOUNDS OF THE INVENTION ARE USED TO TREAT THE SYNDROME OF POLITICAL OVARIES TO AVOID OR DELAY THE ATTACK OF THE DIABETES MELITUS NOT DEPENDENT ON THE INSULIN. IN ANOTHER CONFORMATION, THE COMPOUNDS OF THE INVENTION ARE USED TO TREAT THE GESTATIONAL DIABETES TO AVOID OR DELAY THE MELITUS ATTACK OF THE DIABETES NOT DEPENDENT ON THE INSULIN.
机译:提出了使用噻唑烷酮和相关抗遗传剂的衍生物来治疗人口的新方法,该疾病具有不依赖于胰岛素(NIDDM)的糖尿病和其并发症的危险。在一构想中,本发明的化合物用于治疗政治性卵巢综合症,以避免或延缓不依赖于胰岛素的糖尿病发作的发作。在另一种形式中,本发明的化合物用于治疗妊娠糖尿病,以避免或延缓不依赖于胰岛素的糖尿病的症状发作。

著录项

  • 公开/公告号ES2154685T3

    专利类型

  • 公开/公告日2001-04-16

    原文格式PDF

  • 申请/专利权人 WARNER-LAMBERT COMPANY;

    申请/专利号ES19940928068T

  • 申请日1994-09-09

  • 分类号A61K31/425;A61K31/44;A61K31/41;

  • 国家 ES

  • 入库时间 2022-08-22 01:22:16

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号